Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 29Stomach Neoplasms 25Rectal Neoplasms 25Colonic Neoplasms 13Neoplasms 3Neoplasm Metastasis 3Adenocarcinoma 3Gastrointestinal Neoplasms 2Waldenstrom Macroglobulinemia 1Turcot syndrome 1Recurrence 1Rcctal Cancer 1Peripheral Nervous System Diseases 1Metastatic HER2 Positive Gastroesophageal Junction Cancer 1Locally Advanced Rectal Cancer (LARC) 1Locally Advanced Rectal Cancer 1Locally Advanced Gastric Cancer 1Locally Advanced Colorectal Cancer 1Intestinal Neoplasms 1HER2-positive Locally Advanced Resectable Gastric Cancer 1HER2-positive Colorectal Cancer 1Gastrointestinal Diseases 1Gastric Cancer Stage 1Gastric Adenocarcinoma 1Esophageal Neoplasms 1Digestive System Diseases 1Colorectal Cancer Metastatic 1Colonic Diseases 1Carcinoma 1Adenocarcinoma of the Lower Rectum 1

Interventions

Capecitabine 20Oxaliplatin 13Irinotecan 8spartalizumab 6tislelizumab 4Radiation 4Neoadjuvant Therapy 4Immune Checkpoint Inhibitors 4Fluorouracil 4toripalimab 3sintilimab 2camrelizumab 2Radiotherapy 2Leucovorin 2Celecoxib 2veliparib 1peposertib 1nimotuzumab 1irinotecan sucrosofate 1XELOX 1Thymalfasin 1Radiotherapy, Intensity-Modulated 1Injections 1HMPL-013 1Folfox protocol 1Diathermy 1Combined Modality Therapy 1Chemoradiotherapy 1Amifostine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Locally Advanced Rectal Cancer × XELOX × Clear all
NCT05086627 2024-08-22

Short-course Radiotherapy Followed by Tislelizumab + CapeOX in the Treatment for Locally Advanced Rectal Cancer

Hebei Medical University Fourth Hospital

Phase 2 Completed
118 enrolled
Gastrointestinal

Locally Advanced Rectal Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡